Argenx
ARGX
#408
Rank
ยฃ42.78 B
Marketcap
ยฃ687.10
Share price
-0.63%
Change (1 day)
39.64%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): ยฃ6.64

According to Argenx 's latest financial reports the company's current EPS (TTM) is ยฃ6.65. In 2024 the company made an earnings per share (EPS) of ยฃ10.44 an increase over its 2023 EPS that were of -ยฃ3.87.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ6.64-36.43%
2024ยฃ10.44-369.77%
2023-ยฃ3.87-60.46%
2022-ยฃ9.7963.33%
2021-ยฃ5.99-40.37%
2020-ยฃ10.05183.47%
2019-ยฃ3.55123.09%
2018-ยฃ1.5954.93%
2017-ยฃ1.0314.07%
2016-ยฃ0.9013.05%
2015-ยฃ0.80-36.34%
2014-ยฃ1.25209.04%
2013-ยฃ0.40-33.99%
2012-ยฃ0.61185.59%
2011-ยฃ0.21